Propanolol – Anxiety and Cancer Research
Common heart drug Propranolol, a beta-blocker, may provide anti-anxiety value for select patients with cancer. Propranolol assists by calming down the …
Read articleResearch updates, clinic news and perspectives on integrative cancer care from LEMMO Cancer Care.
Common heart drug Propranolol, a beta-blocker, may provide anti-anxiety value for select patients with cancer. Propranolol assists by calming down the …
Read articleIn a 2025 prospective study from Japan, patients who ate more vinegar-containing foods before starting immune checkpoint inhibitors (i.e. immunotherapy) …
Read articleThe herpes virus Cytomegalovirus (CMV) appears to be commonly found in glioblastoma brain cancers (GBM). Data is linking using the …
Read articleA personalized approach with Prosigna. New data where 2 out of 3 women with hormone positive breast cancer (HER2-negative) over …
Read articleAfter surgery in stage III colorectal cancer, doctors checked ctDNA — a blood test for leftover cancer. The test is …
Read articleAggressive advanced soft tissue sarcoma case report – Myxofibrosarcoma (MFS) – had a long-term 48-month survival despite many negative clinical …
Read articleMistletoe in Osteosarcoma – Upcoming Phase 2 Trial European scientists and clinicians in the US from two pediatric oncology programs …
Read articleThis case report published January 2026 describes an elderly patient with extensive-stage small-cell lung cancer who achieved a near-complete thoracic …
Read articleAllogenic hematopoietic stem cell transplantation (allo-HSCT) is a curative treatment for hematological disorders but often results in micronutrients deficiency and …
Read article